ReviewMolecular neurobiology2026
Neurons Die Not by One Hit, but by Signaling Convergence.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an emerging understanding of neurodegenerative diseases as complex diseases with a combination of multiple interrelated signaling pathways as opposed to one causative factor. This review examines the idea that neurons do not die in a single event, but through convergence of signals, which outlines the different pathological events such as oxidative stress, mitochondrial dysfunction, excitotoxicity, calcium imbalance, impaired proteostasis and neuroinflammation that interact to determine the fate of neurons. The processes are closely connected by molecular nodes like ROS, NF-κB, and MAPK signaling pathways, Nrf2/Keap1 antioxidant axis, and dysregulated autophagy and endoplasmic reticulum stress responses. The review also discusses the contribution of neuron glia interactions and the impact of microglial activation, astrocyte malfunction and cytokine networks in enhancing neuronal damage in a feedback mechanism. Mechanisms that have been mentioned as the oxidative stress inflammation cycle, mitochondrial damage, ROS feedback, and protein aggregation cellular stress loop are cited to be the major contributors to disease progression. Also, the review mentions new biomarkers, multi-omics methods, and sophisticated research instruments, such as artificial intelligence and organoid models, which can contribute to our knowledge of disease pathogenesis and help diagnose it earlier. On the whole, this review presents a complete paradigm on how to perceive neurodegeneration as a systems-level phenomenon. It combines molecular, cellular, and clinical perspectives and offers the rationale for the need to consider the therapeutic approach to neurodegenerative diseases in a holistic and multi-dimensional manner.
Indexed as
Identifiers
42545664What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.